Cargando…

MRP8/14 serum levels as a predictor of response to starting and stopping anti-TNF treatment in juvenile idiopathic arthritis

INTRODUCTION: Approximately 30 % of juvenile idiopathic arthritis (JIA) patients fail to respond to anti-TNF treatment. When clinical remission is induced, some patients relapse after treatment has been stopped. We tested the predictive value of MRP8/14 serum levels to identify responders to treatme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anink, Janneke, Van Suijlekom-Smit, Lisette W. A., Otten, Marieke H., Prince, Femke H. M., van Rossum, Marion A. J., Dolman, Koert M., Hoppenreijs, Esther P. A. H., ten Cate, Rebecca, Ursu, Simona, Wedderburn, Lucy R., Horneff, Gerd, Frosch, Michael, Vogl, Thomas, Gohar, Faekah, Foell, Dirk, Roth, Johannes, Holzinger, Dirk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4528380/ https://www.ncbi.nlm.nih.gov/pubmed/26249667 http://dx.doi.org/10.1186/s13075-015-0723-1

Ejemplares similares

PReS-FINAL-2145: MRP8/14 serum complexes as predictor of response to etanercept treatment in juvenile idiopathic arthritis
por: Anink, J, et al.
Publicado: (2013)

Long term functional outcome and quality of life of patients with refractory juvenile idiopathic arthritis treated with etanercept: results of the dutch arthritis and biologicals in children register
por: Anink, Janneke, et al.
Publicado: (2014)

Review of biomarkers in systemic juvenile idiopathic arthritis: helpful tools or just playing tricks?
por: Gohar, Faekah, et al.
Publicado: (2016)

The TLR4 ligands MRP8 and MRP14 in the diagnosis and pathogenesis of systemic onset juvenile idiopathic arthritis
por: Frosch, M, et al.
Publicado: (2008)

Bone health assessment of patients with juvenile idiopathic arthritis: a comparison between DXA and bonexpert
por: Nusman, Charlotte M, et al.
Publicado: (2014)

Use of MRP8/14 in clinical practice as a predictor of outcome after methotrexate withdrawal in patients with juvenile idiopathic arthritis
por: Sumner, Emma J., et al.
Publicado: (2022)

PReS-FINAL-2216: Biomarkers MRP8/14 and S100A12 correspond with flare and remission clinical status in Sojia patients in the AID-NET register
por: Gohar, F, et al.
Publicado: (2013)

PReS-FINAL-2146: Trends in prescription of biologics and outcomes of juvenile idiopathic arthritis; results of the Dutch national arthritis and biologicals in children register
por: Otten, MH, et al.
Publicado: (2013)

Automated determination of bone age and bone mineral density in patients with juvenile idiopathic arthritis: a feasibility study
por: Anink, Janneke, et al.
Publicado: (2014)

2-year outcome of juvenile idiopathic arthritis in current daily practice: what can we tell our patients?
por: Anink, Janneke, et al.
Publicado: (2011)

Etanercept in juvenile idiopathic arthritis: Who will benefit?
por: Otten, MH, et al.
Publicado: (2011)

OR6-004 – MRP8/14 promote MSU-crystal induced inflammation
por: Holzinger, D, et al.
Publicado: (2013)

Patient-reported joint count in juvenile idiopathic arthritis: the reliability of a mannequin format
por: Anink, Janneke, et al.
Publicado: (2014)

Myeloid-related protein (MRP) 8 and MRP 14 in rheumatoid arthritis and spondyloarthropathy
por: De Rycke, L, et al.
Publicado: (2003)

Serum MRP8/MRP14 as a biomarker for inflammation in autoimmune arthritis
por: De Rycke, L, et al.
Publicado: (2004)

The role of S100 proteins in the pathogenesis and monitoring of autoinflammatory diseases
por: Holzinger, Dirk, et al.
Publicado: (2018)

Development of a web-based register for the Dutch national study on biologicals in juvenile idiopathic arthritis: http://www.abc-register.nl
por: Prince, FHM, et al.
Publicado: (2008)

The endogenous TLR-4 ligands MRP8/14 as biomarkers of inflammation in Familial Mediterranean Fever (FMF)
por: Wittkowski, H, et al.
Publicado: (2008)

MRP8/14 and neutrophil elastase for predicting treatment response and occurrence of flare in patients with juvenile idiopathic arthritis
por: Barendregt, Anouk M, et al.
Publicado: (2020)

Driving Medical Innovation Through Interdisciplinarity: Unique Opportunities and Challenges
por: Gohar, Faekah, et al.
Publicado: (2019)

Significant pain decrease in children with non-systemic Juvenile Idiopathic Arthritis treated to target: results over 24 months of follow up
por: Spekking, Katinka, et al.
Publicado: (2023)

When and how to stop etanercept after successful treatment of patients with juvenile idiopathic arthritis
por: Prince, FHM, et al.
Publicado: (2008)

Can inflammatory markers predict response to methotrexate in JIA? Results from the CHARM study
por: Moncrieffe, H, et al.
Publicado: (2011)

Multidrug resistance-associated protein-1 (MRP1) genetic variants, MRP1 protein levels and severity of COPD
por: Budulac, Simona E, et al.
Publicado: (2010)

The Translational Medicine Professional: A Bridge Between Bench and Bedside?
por: Gohar, Faekah, et al.
Publicado: (2018)

A novel serum calprotectin (MRP8/14) particle-enhanced immuno-turbidimetric assay (sCAL turbo) helps to differentiate systemic juvenile idiopathic arthritis from other diseases in routine clinical laboratory settings
por: Foell, Dirk, et al.
Publicado: (2023)

Prevention of disease flares by risk-adapted stratification of therapy withdrawal in juvenile idiopathic arthritis: results from the PREVENT-JIA trial
por: Gerss, Joachim, et al.
Publicado: (2022)

Characterization of SN38-resistant T47D breast cancer cell sublines overexpressing BCRP, MRP1, MRP2, MRP3, and MRP4
por: Lee, Hee-Jeong, et al.
Publicado: (2022)

Potent interaction of flavopiridol with MRP1
por: Hooijberg, J H, et al.
Publicado: (1999)

Parental preferences for treatment: Preliminary report from a randomised comparison of treatment strategies in (early) juvenile idiopathic arthritis (BeSt for Kids trial)
por: Muller, PCE Hissink, et al.
Publicado: (2011)

The diagnostic and prognostic value of MRP8/MRP14 in intrahepatic cholangiocarcinoma
por: Jin, Guang-Zhi, et al.
Publicado: (2015)

Involvement of human and canine MRP1 and MRP4 in benzylpenicillin transport
por: Zhao, Xiaofen, et al.
Publicado: (2019)

Joint inflammation assessed by physical examination and MRI of the knee in juvenile idiopathic arthritis: low predictive value for synovitis
por: Nusman, Charlotte M, et al.
Publicado: (2014)

14.6 MRP-Targeting in experimental rheumatoid arthritis allows monitoring of disease activity with optical molecular imaging
por: Eisenblätter, M, et al.
Publicado: (2008)

A survey of national and multi-national registries and cohort studies in juvenile idiopathic arthritis: challenges and opportunities
por: Beukelman, Timothy, et al.
Publicado: (2017)

Participation in a single-blinded pediatric therapeutic strategy study for juvenile idiopathic arthritis: are parents and patient-participants in equipoise?
por: Hissink Muller, Petra C. E., et al.
Publicado: (2018)

The German version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
por: Holzinger, Dirk, et al.
Publicado: (2018)

PReS-FINAL-1001: Lymphocytes from the inflamed joint of juvenile idiopathic arthritis patients express reduced levels of cd73 and have a functional defect in adenosine production
por: Botta Gordon-Smith, S, et al.
Publicado: (2013)

PReS-FINAL-2109: Genetic variations in patients with juvenile idiopathic arthritis and uveitis
por: Reinards, TH, et al.
Publicado: (2013)

The subcellular distribution of myeloid-related protein 8 (MRP8) and MRP14 in human neutrophils
por: Stroncek, David F, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_svglkl8nrenopu3sb0qkboncav